Biomedical Catalyst 2023 Round 2: Industry-led R&D

UK registered SMEs can apply for a share of up to £20 million to develop innovative solutions to health and healthcare challenges. This funding is from Innovate UK.

Innovate UK, part of UK Research and Innovation, will invest up to £20 million in projects to support UK-registered businesses to develop innovative solutions to address significant health or healthcare challenges.

Your project can focus on:

• disease prevention and proactive management of health and chronic conditions
• earlier and better detection and diagnosis of disease, leading to better patient outcomes
• tailored treatments that either change the underlying disease or offer potential cures
• transforming the delivery of healthcare
• the development of digital health technologies
• consumer focused self-care

This list is not intended to be exhaustive.

The Industry led research and development (R&D) stream of the Biomedical Catalyst programme supports pre-market R&D projects. Applicants must be able to demonstrate existing evidence of commercial and technical feasibility.

Applications must show how they will improve the competitiveness and productivity of at least one UK SME involved in the project.

In applying to this competition, you are entering into a competitive process. This competition closes at 11am UK time on the deadline stated.

Project size: Your project’s total costs must be between £150,000 and £4 million. The total grant cannot exceed £2 million.